发明名称 |
COMBINATION THERAPY FOR COPD |
摘要 |
<p>The invention concerns an aerosol formulation suitable for administering to COPD patients by means of a pressurized metered dose inhaler (pMDI), comprising glycopyrronium bromide in combination with formoterol. The formulation further comprises a HFA propellant, a co-solvent, and an amount of inorganic acid sufficient to stabilize both the glycopyrronium bromide and the formoterol components. Optionally the formulation further comprises beclometasone dipropionate.</p> |
申请公布号 |
SG181868(A1) |
申请公布日期 |
2012.07.30 |
申请号 |
SG20120046157 |
申请日期 |
2010.12.22 |
申请人 |
CHIESI FARMACEUTICI S.P.A. |
发明人 |
BONELLI, SAURO;USBERTI, FRANCESCA;ZAMBELLI, ENRICO |
分类号 |
|
主分类号 |
|
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|